• Home
  • About Us
    • Management
    • Thrust Areas
    • Disclaimer
    • Dr Boominathan’s Quotes
  • Ideas
    • Bio-Med Ideas
      • Ideas for Free
      • Bio-Pharma/Med Ideas
      • Audience Profile
      • Bio-Medical Ideas-7,900+
      • Bio-Med Res Grants Aid
      • p63 and p73 Community
      • How p63/p73/p53 Field Progresses
      • Noble Laureate’s work tracked by GBMD
      • Ideas were viewed by World’s Best 10 Universities
      • Submit your Ideas
    • miRNA Therapeutics
      • Intellectual Property Development
      • Licensing Opportunities
      • Partnerships
      • Investor opportunities
      • Educational Tools
      • Scientific Resources
  • Research
    • Research Focus
    • Research Themes
    • Research – II
    • Dr Boomi’s Contributions (Res)
    • Dr Boomi’s caliber (Sci)
    • Conference publications
    • Research Publications
    • Research Training
    • Ph.D/M.D/M.Tech Mentor
    • What Scientists Saying
    • Peer/Manuscript Review
    • Press/Media Release
    • Conferences/Meetings
  • B-MERIIT
    • Introduction
    • Founder
    • What We Assure
    • M.S program
      • M.S in Molecular Cancer Biology
      • M.S in Stem cell Biology & Regenerative Medicine
      • M.S in Mol. Medicine
      • M.S in Genome Biology
      • M.S in Bio-Medical Sciences
  • Model Building & Model Laboratory
    • Investor opportunities
    • Logo
    • Career guidance
    • Admission Details
  • Registration
    • Terms and conditions
  • Career/Opportunities
  • Contact Us

[GBMD] / [B-MERIIT]

Address:

No.101, 12th Cross,
Rainbow Nagar,
Puducherry-605 001, India.

Contact us:

0091-413-235-5879
Drboomi@genomediscovery.org

Biotox Gold Reviews

Research

  • Research Focus
  • Research Themes
  • Research – II
  • Dr Boomi’s Contributions (Res)
  • Dr Boomi’s caliber (Sci)

Recent Posts

  • PTC299-based therapy for COVID-19/SARS-COV-2 and other infectious diseases: PTC299, an anti-cancer drug, inhibits SARS-COV-2, Hepatitis-B/C, Dengue, Zika, Ebola, HIV-1, Mtb, Malaria, CMV, Influenza H1NI1,  Foot and Mouth disease, ADV, respiratory syncytial, Sindbis, and SFV viruses and others by increasing the levels of IFN (Interferon)-alpha/alpha-2/beta/gamma/lamda, interferon-inducible transmembrane protein IFITM3, Interferon-stimulated gene-15, Mx2 and antimicrobial peptides and decreasing the expression of inflammatory cytokines 24/October/2020, 9.39 am
© 2017 Genome Discovery. All Rights Reserved. Design by Staunch